An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

BACKGROUND: Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of COVID-19 was reported on March 11. Elderly with multiple comorbidities have been the most risky population. Although most patients present a mild to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saavedra, Danay, Añé-Kourí, Ana Laura, Sánchez, Naivy, Filgueira, Lázaro Manuel, Betancourt, Julio, Herrera, Carlos, Manso, Leniel, Chávez, Elibet, Caballero, Armando, Hidalgo, Carlos, Lorenzo, Geydi, Cepeda, Meylan, Valenzuela, Carmen, Ramos, Mayra, León, Kalet, Mazorra, Zaima, Crombet, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666403/
https://www.ncbi.nlm.nih.gov/pubmed/33292350
http://dx.doi.org/10.1186/s12979-020-00207-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666403/
https://www.ncbi.nlm.nih.gov/pubmed/33292350
http://dx.doi.org/10.1186/s12979-020-00207-8

Ejemplares similares